HAOMIAO TECHNOLOGY
831856
Anhui Bossco Environmental Protection Technology
300422
MH Robot & Automation
301199
ASR Microelectronics
688220
Fibocom Wireless Inc.
300638
CN Stock MarketDetailed Quotes
000739 Apeloa Pharmaceutical
- 15.38
- -0.07-0.45%
Trading Jan 21 13:46 CST
17.98BMarket Cap16.75P/E (TTM)
15.54High15.21Low28.04KlotVolume15.50Open15.45Pre Close42.97MTurnover0.24%Turnover Ratio17.03P/E (Static)1.17BShares18.9652wk High2.73P/B17.98BFloat Cap10.3552wk Low17.00Limit Up1.17BShs Float40.98Historical High13.91Limit Down2.14%Amplitude-1.06Historical Low0.32Dividend TTM15.33Avg Price15.83KlotAsk2.06%Div YieldTTM100Lot Size11.19KlotBid
Apeloa Pharmaceutical News
Prologis Pharmaceuticals: 2025-02. Announcement on the approval of a new production site for bupropion hydrochloride extended-release tablets (XL) from the US FDA
Pro-Pharmaceuticals: Announcement on Obtaining a Notice of Approval for Clinical Trials of Drugs
Prologis Pharmaceuticals: Announcement on the receipt of government subsidies by the company and its subsidiaries
Prologis Pharmaceuticals: Announcement on the progress of guarantees for subsidiary companies
Pro-Pharmaceuticals: Announcement on Obtaining a Drug Registration Certificate
Pro-Pharmaceuticals: Announcement on Obtaining a Notice of Approval of the Application for the Marketing of Chemical Ingredients
Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies
Prologis Pharmaceutical: 2024-58. Announcement on signing a strategic cooperation framework agreement
Pro-Pharmaceuticals: Announcement on Obtaining a Drug Registration Certificate
Pro-Pharmaceuticals: Announcement on Obtaining a Notice of Approval of the Application for the Marketing of Chemical Ingredients
Pro-Pharmaceuticals: Notice on Obtaining a Notice of Approval for Drug Supplementary Applications
Pro-Pharmaceuticals: Announcement on Obtaining a Notice of Approval of the Application for the Marketing of Chemical Ingredients
Pro-Pharmaceuticals: Announcement on Obtaining a Drug Registration Certificate
Pro-Pharmaceuticals: Notice on Obtaining a Notice of Approval for Drug Supplementary Applications
Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies
Prologis Pharmaceuticals: Investor Relations Activity Record Form for October 18, 2024
Prologis Pharmaceuticals: Report for the third quarter of 2024
Prologis Pharmaceuticals: Announcement on amantadine hydrochloride tablets being approved for marketing by the US FDA
Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies
Prologis Pharmaceutical: Announcement on the expiration of the share repurchase period and the implementation results of the repurchase
